174 related articles for article (PubMed ID: 34112319)
1. AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
Hinkel R; Batkai S; Bähr A; Bozoglu T; Straub S; Borchert T; Viereck J; Howe A; Hornaschewitz N; Oberberger L; Jurisch V; Kozlik-Feldmann R; Freudenthal F; Ziegler T; Weber C; Sperandio M; Engelhardt S; Laugwitz KL; Moretti A; Klymiuk N; Thum T; Kupatt C
J Am Coll Cardiol; 2021 Jun; 77(23):2923-2935. PubMed ID: 34112319
[TBL] [Abstract][Full Text] [Related]
2. AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury.
Hinkel R; Ramanujam D; Kaczmarek V; Howe A; Klett K; Beck C; Dueck A; Thum T; Laugwitz KL; Maegdefessel L; Weber C; Kupatt C; Engelhardt S
J Am Coll Cardiol; 2020 Apr; 75(15):1788-1800. PubMed ID: 32299591
[TBL] [Abstract][Full Text] [Related]
3. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
[TBL] [Abstract][Full Text] [Related]
5. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.
Gogiraju R; Xu X; Bochenek ML; Steinbrecher JH; Lehnart SE; Wenzel P; Kessel M; Zeisberg EM; Dobbelstein M; Schäfer K
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713289
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload.
Hedhli N; Lizano P; Hong C; Fritzky LF; Dhar SK; Liu H; Tian Y; Gao S; Madura K; Vatner SF; Depre C
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1385-93. PubMed ID: 18676687
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload-Induced Heart Failure.
Kim SK; Biwer LA; Moss ME; Man JJ; Aronovitz MJ; Martin GL; Carrillo-Salinas FJ; Salvador AM; Alcaide P; Jaffe IZ
Circ Heart Fail; 2021 Feb; 14(2):e007279. PubMed ID: 33517669
[TBL] [Abstract][Full Text] [Related]
10. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
11. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Ben-Nun D; Buja LM; Fuentes F
Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
[TBL] [Abstract][Full Text] [Related]
13. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
[TBL] [Abstract][Full Text] [Related]
14. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
16. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
[TBL] [Abstract][Full Text] [Related]
17. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
[TBL] [Abstract][Full Text] [Related]
18. Effects of hawthorn on the progression of heart failure in a rat model of aortic constriction.
Hwang HS; Boluyt MO; Converso K; Russell MW; Bleske BE
Pharmacotherapy; 2009 Jun; 29(6):639-48. PubMed ID: 19476417
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload-Induced Heart Failure.
LaRocca TJ; Seeger T; Prado M; Perea-Gil I; Neofytou E; Mecham BH; Ameen M; Chang ACY; Pandey G; Wu JC; Karakikes I
Circ Heart Fail; 2020 Mar; 13(3):e006298. PubMed ID: 32160771
[TBL] [Abstract][Full Text] [Related]
20. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.
Sakata Y; Hoit BD; Liggett SB; Walsh RA; Dorn GW
Circulation; 1998 Apr; 97(15):1488-95. PubMed ID: 9576430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]